Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Head-Neck
Study Phase
Phase 2BPhase 3
Study Completion Date
June 2003
NCT00401323Uploaded 06-22-2015
Available for Download
PDS UID: HeadNe_SanofiU_1998_142
A Randomized Phase II-III Multicenter Trial of Docetaxel Plus Cisplatin and Docetaxel Plus 5-FU Versus Cisplatin Plus 5-FU in 1st Line Treatment of Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.
Files:
PROTOCOLsanofi_xrp6976_efc6051_protocol_and_amendments_redacted.pdf
CRFsanofi_xrp6976_efc6051_CRF_redacted.pdf
DATA DICTIONARYXRP6976_EFC6051_datasphere.xls
DATA (COMPARATOR ARM)sanofi_xrp6976_efc6051_datasets_and_readme.zip